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Abstract
Assembly of ERMES Subunit Mdm12 and its Interaction with Synthetic Lipid Bilayers
Adrian Coscia, University Scholar Program
University of Connecticut
2017
The endoplasmic reticulum—mitochondria encounter structure (ERMES) is a tethering
complex that mediates the close apposition of ER and mitochondrial membranes. The ERMES
complex consists of at least four proteins: the ER transmembrane protein Mmm1, the
mitochondrial outer membrane (OM) protein Mdm34, the OM β-barrel protein Mdm10, and the
cytosolic protein Mdm12. Accumulating evidence suggests that the ERMES complex provides
the molecular basis for non-vesicular phospholipid transport between the ER and mitochondria.
Yet how these subunits assemble into a quaternary membrane tether is poorly understood, and
the mechanism of ERMES-mediated phospholipid transport has yet to be revealed. Both of these
aspects are necessary prerequisites for developing a thorough picture of not only lipid transport
at ER—mitochondria contact sites, but of non-vesicular lipid transport in general. Here we show
that full-length Mdm12 of S. cerevisiae exists primarily as a disulfide-mediated dimer in
dynamic equilibrium. We also demonstrate novel features of Mdm12—bilayer interaction, in
particular that Mdm12 induces fusion, lysis, solubilization, and aggregation of synthetic lipid
bilayers. The results show that the reductant DTT and calcium both modulate the kinetics of
Mdm12 lipid binding. Structural aspects of Mdm12 lipid-binding specificity are also addressed
by in silico phospholipid docking.
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Introduction
I. The Endoplasmic Reticulum-Mitochondria Junction
Many processes within eukaryotic cells depend on dynamic membrane-bound organelles
that segregate specific metabolic processes into compartmentalized microenvironments. Yet cells
must also choreograph the transport of proteins, signaling molecules, lipids, and other
metabolites between sets of organelles for appropriate function. Intracellular membrane contact
sites (MCS) were first identified by electron microscopy as tightly coordinated associations
between organelles1. In particular, specialized domains of the endoplasmic reticulum (ER),
termed mitochondrial-associated membranes (MAMs), form zones of close (~10-50 nm)
apposition with the mitochondrial outer membrane (OM)1-5 (Fig. 1A). These junctions play a
number of critical roles in signaling, metabolism, and organelle dynamics that require
coordination between the ER and mitochondria.
Of particular interest, lipid biogenesis requires the transport of lipids between the ER (the
major site of lipid synthesis) and the mitochondrion (Fig. 1A, left). Mitochondria contain

A

B

Figure 1. The ERMES Complex
A) The ER-mitochondrial junction tethered by
ERMES (subunits: Mmm1, red; Mdm10, yellow;
Mdm34, green; Mdm12, cyan). Phospholipid trafficking routes (left) comprise transport to mitochondria
(solid lines) and transport to the ER (dotted lines).
Ca2+ exchange (right) occurs from the IP3R channel to
the mitochondrial uptake machinery (VDAC/MCU).
B) ERMES subunits and domain organization.
Subunits are depicted with relevant residues (Saccharomyces cerevisiae numbering). Abbreviations:
TMS, transmembrane segment; SMP, synaptotagmin-like, mitochondrial lipid binding protein.
(Image courtesty of Dr. Nathan Alder)
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enzymes necessary to synthesize some resident phospholipids [e.g. phosphatidic acid (PA),
phosphatidylethanolamine (PE), phosphatidylglycerol (PG) and cardiolipin (CL)], but other
lipids must be imported from their primary site of synthesis on the ER/MAM membrane6. For
instance phosphatidylserine (PS) first synthesized on the ER is decarboxylated to PE in the
mitochondrial inner membrane (IM) and trafficked back to the ER, where it can be further
modified into phosphatidylcholine (PC)7 (Fig. 1A). PC and PE are the two most abundant
phospholipids in many biological membranes, and consequently several organisms depend on PS
decarboxylation in mitochondria as the major source of PE necessary for appropriate function.
Importantly, because mitochondria are not part of the endomembrane system, this bidirectional
lipid transport must be non-vesicular8. Clearly, this bidirectional lipid trafficking is a
fundamental process in organellar biogenesis.
The second preeminent function of the ER-mitochondria contact site is interorganellar
Ca2+ signaling (Fig. 1A, right). Mitochondrial Ca2+ uptake is critical for cellular Ca2+
homeostasis, the regulation of mitochondrial enzymes, and has been linked to pathologies such
as cancer, Alzheimer’s disease, and Parkinson’s disease9-14. Upon stimulus, transmembrane IP3
receptors (IP3R) release Ca2+ stored in the ER, forming microdomains of high calcium
concentration (20-40 µM) in close proximity (~15 nm) to ER-mitochondria contact sites15-17.
Ca2+ uptake at the mitochondrial OM is mediated by the non-specific voltage-dependent anion
channel (VDAC), which is coupled to the inner membrane Ca2+ uniporter (MCU)18-20. Notably,
because the affinity of MCU for Ca2+(20-30 µM) is lower than cytosolic Ca2+ concentration,
these microdomains are required for MCU-mediated response16, 17, 18. It follows that distance
plasticity between juxtaposed membranes may be important in regulating mitochondrial Ca2+
response5.
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II. The ERMES Complex
In 2009 a synthetic biology screen in Saccharomyces cerevisiae led to the identification
of the ER-mitochondria encounter structure (ERMES), a tethering complex that mediates ERmitochondrial association21. The ERMES complex is localized to discrete punctae at contact sites
and consists of at least four proteins: the ER-anchored protein Mmm1, the mitochondrial protein
Mdm34, the OM β-barrel protein Mdm10, and the cytosolic protein Mdm12 (Fig. 1A). A
subsequent study identified the Ca2+-binding Miro GTPase Gem1 as an integral and regulatory
component of ERMES22. In addition to its conspicuous role as a membrane tether, initial genetic
interaction screens and biochemical studies implicated the ERMES complex in lipid transport,
Ca2+ exchange, protein transport, establishment of mitochondrial morphology and mitochondrial
division, and inheritance of mitochondrial DNA23-27. However, because ER-mitochondria contact
sites are dynamic structures with several co-localized multisubunit complexes, it has proven
difficult to discriminate between direct and indirect ERMES functions. For example, the role of
ERMES in PS transfer has been controversial, confounded by redundancy in lipid transport
mechanisms between mitochondria and the rest of the cell23, 26, 32.
Bioinformatic and structural analyses also support the idea that ERMES plays a role in
lipid trafficking. SMP (synaptotagmin-like, mitochondrial and lipid-binding protein) domains
have been identified in Mdm12, Mdm34, and Mmm128 (Fig. 1B). SMP domain-containing
proteins have been placed within the TULIP (tubular lipid-binding protein) superfamily of lipid /
hydrophobic ligand-binding proteins, of which several protein structures are known29. In known
TULIP structures with bound lipids, lipid acyl chains bind to the SMP channel lumen whereas
lipid head groups lie outside the channel29. A recently published crystal structure confirmed the
SMP domain of Mdm12 binds phospholipids in this manner30 (Fig. 2A).
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Figure 2. Putative Structure of Mdm12-Mmm1 Ternary Complex
A) Crystal structure of Mdm12 dimer from S. cerevisiae refined to 3.1 Å resolution. Disordered loop (74-113) and C-terminal residues (268-271) not shown.
Bound lipids are depicted by black stick models.
B) Putative Mdm12-Mmm1 assembly. Mmm1 (magenta/red) homodimer anchored to ER membrane shown binding Mdm12 (yellow) monomers via tail contacts distal to Mdm12 dimer interface.
C) Heterotetramer of Mdm12/Mmm1∆5 (Mmm1∆1-122) by EM random conical tilt (RCT) reconstruction to 35 Å resolution.
D) Heterotetramer of Mdm12/Mmm1∆1 (Mmm1∆1-161) by EM RCT reconstruction with applied two-fold symmetry to 17 Å resolution. Envelope has
dimensions of ~210 x 45 x 35 Å.
Panels A/B adapted from Jeong H., et al. 2016. (ref. 30)
Panels C/D adapted from AhYoung A.P., et al. 2015. (ref 31)

Biochemical analysis and EM reconstruction further suggest subunits Mdm12 and
Mmm1 assemble into higher-order structure via SMP domain-mediated interactions, although
the structural basis of this assembly remains unknown31 (Fig. 2C and D). Moreover, both
Mdm12 and Mmm1 have been shown to be bona fide lipid-binding proteins with a preference for
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PC, and to a lesser extent PI30,31. However, the lipid-binding properties and the assembly of
ERMES subunits are still poorly understood. Additionally, no high-resolution structure of
Mmm1, Mdm34, Mdm10, or any ERMES components in complex has been published.

III. Assembly and Lipid-Binding of Mdm12
Lipidomic and biochemical studies addressing Mdm12 lipid-binding specificity have
demonstrated that Mdm12 capably binds several different species of phospholipids with
appreciable affinity. Independent studies using quantitative mass spectrometry (MS) have shown
that Mdm12 expressed in Escherichia coli co-purifies with predominantly PE and PG (~80% and
~15% respectively)30,31. Displacement assays also demonstrate that PC, PE, PG, and to a lesser
extent PI, all bind Mdm12 in vitro. Interestingly, MS analysis of Mdm12 incubated with
liposomes of native yeast phospholipid composition revealed a two-fold enrichment of bound PC
(~60%) relative to native composition (~27%), suggesting PC may be an endogenous ligand in
vivo31. However, these in vitro biochemical studies stand in apparent contradiction to the finding
that the ERMES complex specifically transports PS23,32.
Recently published crystal structures of Mdm12 from S. cerevisiae revealed a dimer with
an elongated tubular structure containing bound phospholipids30 (Fig. 2A). The SMP domain of
the Mdm12 monomer closely resembles the topology of SMP domains in related proteins of
known structure (Fig. 3). As in E-SYT2 the SMP domains in Mdm12 dimerize, whereas other
members of the TULIP superfamily (e.g. BPI and CETP) contain two tandem SMP domains
constituted by a single monomer33-35. The full-length of structure of Mdm12 details a unique β1
domain swap that mediates self-assembly at the dimerization interface. Highly conserved β1-
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strands from each Mdm12 monomer form an intercalated hydrogen-bonding network between
the β1- and β2-strands of the respective adjoining monomer (Fig 3A). This is a distinctive
feature of Mdm12 not yet observed in any other SMP domain-containing proteins, suggesting
that Mdm12 lipid binding may be governed by unique dynamics. For example, Mdm12 β1-strand
mutants bind lipid with greater apparent affinity30. It is possible that Mdm12 monomer-dimer
equilibrium serves some role in the dynamic organization of MAMs as it exists in vivo.

Figure 3. Comparison of Mdm12 to
known TULIP Superfamily Proteins.
A) Dimer interface of Mdm12 mediated
by a β1-domain swap (inset) is unique
among SMP domain-containing proteins.
Sequence conservation of the β1-strand
(residues 1-7) are shown for ten orthologs.
B) Known TULIP proteins are structurally similar to Mdm12 [(E-SYT2, RMSD:
5.71), (CETP, RMSD: 4.47), (BPI, RMSD:
4.26)]. The dimerization interface of
E-SYT2 is characterized by highly
conserved helices, in contrast to the β1
domain swap in Mdm12. The two-fold
symmetrical interface between the tandem
SMP domains of CETP and BPI are both
comprised of six-stranded central β-sheets.

A

Figure adapted from Jeong H., et al. 2016 (ref. 30)

B
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Figure 4. Structural Basis for Glycerophosphilipid Selectivity of Mdm12. Views of structural
features suggesting Mdm12 may have preference for phospholipids containing positively
charged functional groups in the headgroup region. A surface representation colored by electrostatic potential (left) shows negative charge density proximal to modeled PE head-group. The
same view colored by sequence conservation (right) indicates negatively charged residues are
highly conserved among Mdm12 orthologs.

Structural evidence also suggests Mdm12 preferentially binds phospholipids containing
Figure adapted from Jeong H., et al. 2016. (ref. 30)

cationic functional groups. In particular, conserved acidic residues proximal to dimerization
interface of Mdm12 contribute to a strong negative surface charge that may provide a structural
basis for head-group selectivity (Fig. 4). Displacement assays performed with a surface charge
mutant corroborated the structure-driven hypothesis. Of note, there was no electron density
observed for the C-terminus (also proximal to the head-group of bound lipids) of any Mdm12
monomer in the crystal structure, and whether it plays a dynamic role in lipid binding is
unknown. Additionally the authors observed no electron density for non-conserved residues 74114. A crystal structure of ∆Mdm12 (∆74-114) demonstrated that the major features of fulllength Mdm12 are preserved without these residues. Yet despite no apparent sequence
conservation, several Mdm12 orthologs contain a corresponding non-conserved sequence of
variable length (Fig. 5). Although generality may not be drawn from the role of this region of
Mdm12 from S. cerevisiae, this non-homologous region may contribute to unique plurality of
Mdm12 function at membrane contact sites in different species.
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Figure adapted from
Jeong H., et al. 2016 (ref. 30)

Figure 5. Sequence Conservation of Mdm12. Sequence alignment to Mdm12
orthologs in fungi. Completely and highly conserved residues shown in red and
yellow, respectively. Secondary structural elements are represented as follows:
helices--yellow, strands--green, loops--solid line, disordered--dotted line.
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Materials and Methods
I. Cloning and Protein Purification
cDNA encoding full-length Mdm12 WT from S. cerevisiae were each cloned into a
pET28a vector containing an N-terminal His6-tag. Mdm12 ∆C92S was generated by site directed
mutagenesis of the Mdm12 WT construct, and confirmed by sequencing. Constructs were
transformed into E. coli BL21 (DE3) cells and grown at 37˚C to an OD600 of 0.7 before overnight
induction with 1 mM IPTG at 18˚C. Cells were then harvested by ultracentrifugation,
resuspended in lysis buffer (20 mM HEPES [pH 7.4], 100 mM NaCl) supplemented with 1 mM
PMSF, and lysed by probe sonication at 4˚C. Mdm12 was purified at 4˚C using Ni-NTA
chromatography, followed by gel filtration chromatography (Superdex 75 10/300 GL, GE
Healthcare) and eluted in lysis buffer. Mdm12 WT ∆Ca2+ (calcium removed) was subject to
dialysis against an EDTA-containing buffer (20 mM HEPES [pH 7.4], 100 mM NaCl, 5 mM
EGTA) prior to gel filtration. Protein was concentrated by centrifugation and flash frozen using
liquid nitrogen as needed.

II. Analytical Ultracentrifugation (AUC)
Sedimentation velocity experiments were conducted at either 20˚C or 5˚C and
centrifuged 40,000 RPM. Measurements were taken using an analytical ultracentrifuge
(Beckman-Coulter XL-I) equipped with absorbance optics. Samples were first loaded into double
sector cells fitted with quartz windows, equilibrated in the centrifuge for ~1 hour at the
respective temperature, and then accelerated to the final rotor speed (40,000 RPM). Absorbance
measurements at 280 nm were acquired at 4.5 minute intervals for ~9.5 hours. The experiment
was performed at multiple concentrations for each experiment. Continuous sedimentation
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coefficient distribution, c(s), analysis was performed using a resolution of 0.05S and maximum
entropy regularization with a 95% confidence limit to determine the sedimentation coefficients
for each species in the sample.

III. Liposome preparation and characterization.
All lipids (POPC, POPE, TOCL, NBD-PE) were provided as chloroform stocks from
Avanti Polar Lipids. Lipids were dried under a nitrogen stream for 20 min and lipids films were
subsequently desiccated overnight. Lipids were hydrated in reaction buffer (20 mM HEPES [pH
7.5], 100 mM NaCl) for 30 min, and extruded (≥13 times) manually using a mini-extruder at
room temperature through a 0.1µm polycarbonate membrane (Avanti Polar Lipids, USA) to form
large unilamellar vesicles (LUVs). The final total lipid concentration of the extruded LUVs was
measured using an ammonium ferrothiocyanate colorimetric analysis37. Dynamic light scattering
measurements were obtained from backscatter intensities measured at 25˚C using a Zetasizer
Nano ZS (Malvern Instruments, Worcestershire, U.K.) as described below. The size and
morphology of 100% NBD-PE LUVs was confirmed by transmission electron microscopy
(TEM), also described below.

IV. Native PAGE Analyses
Effect of reductant (DTT). Purified Mdm12 WT and Mdm12 ∆C92S (16.2 µM) in
reaction buffer was mixed with increasing concentrations of DTT and incubated with an
equimolar ratio of NBD-PE(18:1) (100% NBD-PE LUVs prepared as described in appendix
A.II) at room temperature for 45 min. Reactions were resolved on a 12% acrylamide native gel
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and Mdm12 was visualized by Coomassie stain. Fluorescence was visualized by FITC scans
using a PharosFXPlus Gel Imager (Bio-Rad) and Image Lab 3.0 software.
Effect of calcium. Purified Mdm12 ∆Ca+2 and calcium-reintroduced Mdm12 ∆Ca+2 (5.8
µM) were pre-incubated with reaction buffer and calcium-supplemented buffer (20 mM HEPES
[pH 7.4], 100 mM NaCl, 500 µM CaCl2), respectively, for 5 min. Samples were then mixed with
increasing concentraitons of DTT and incubated with an equimolar ratio of NBD-PE(18:1)
(100% NBD-PE LUVs prepared as described in appendix A.II) at room temperature for 45 min.
Reactions were resolved on a 12% acrylamide native gel and in-gel fluorescence was visualized
using a PharosFXPlus Gel Imager (Bio-Rad) and Image Lab 3.0 software.

V. Docking with Glide
Preparation of Mdm12. The crystal structure of full-length Mdm12 (PDB 5GYD) was
prepared using the Protein Preparation Wizard workflow in Maestro (Schrödinger). Hydrogen
atoms were added to the biological unit structure during preprocessing, however missing loops
remained omitted. Heteroatom states were generated using Epik (pH: 7.0 ± 2.0). Hydrogen bond
assignments

were

optimized

and

restrained

TABLE I. LIPID LIBRARY FOR GLIDE DOCKING

minimization (OPLS3 Force Field) was performed to
yield the final prepared structure.
Ligand library generation and preparation.
A phospholipid library was manually curated for
Mdm12 docking. SDF files were downloaded from
the LIPID Metabolites and Pathways Strategy
database (LIPID MAPS).
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Phospholipid	
  

Fatty Acid Composition

PC	
  (32:1)	
  
	
  
	
  
	
  

(14:0/18:2(11Z,14Z))	
  
(14:0/18:2(9Z,12Z))	
  
(14:1(9Z)/18:1(9Z))	
  
(16:1(9Z)/16:1(9Z))	
  

PE	
  (34:2)	
  

(16:1(9Z)/18:1(9Z))	
  

PG	
  (34:1)	
  
	
  

(16:0/18:1(9Z))	
  
(18:1(9Z)/16:0)	
  

PI	
  (32:1)	
  
	
  
	
  

(14:0/18:1(9Z))	
  
(14:1(9Z)/18:0)	
  
(16:0/16:1(9Z))	
  

PS	
  (34:1)	
  
	
  

(16:0/18:1(9Z))	
  
(16:1(9Z)/18:0)	
  

The previously identified30,31 predominant Mdm12-bound S. cerevisiae phospholipid species
PC(32:2) and PG(34:1) were included, in addition to PE(34:2), PI(32:1) and PS(34:1). Fatty acid
compositions of each respective species naturally present in S. cerevisae were included in the
library (Table 1)36. 3-dimensional models of library lipids were subsequently prepared using
LigPrep (Schrödinger) with SDF-defined stereochemical contraints. Epik was used to generate
ionization states (pH: 7.0 ± 2.0) and OPLS3 used for restrained minimization.	
  
Receptor grid generation. The receptor grid was generated for one monomer (PDB
5GYD//B) of the Mdm12 homo-dimer automatically by identifying the co-crystallized ligand.
Ser260 was defined as a rotatable group and the default van der Waals radius scaling factor (1.0)
and partial charge cutoff (0.25) were kept and subject to OPLS3 force field. A second grid was
generated with a headgroup NOE for subsequent constrained PC docking.
Glide Extra Precision (XP) ligand docking. XP flexible ligand docking was performed
using Glide38 (Schrödinger). Default settings including ligand van der Waals scaling (0.80) and
partial charge cutoff (0.15) were used. Post-docking minimization was performed on the ten best
poses for each ligand and a maximum of three poses per ligand were reported. Per-residue
interaction scores for residues within 12.0Å of the ligand were written to the report file.

VI. Dynamic Light Scattering (DLS)
Mdm12-mediated liposome remodeling. Purified Mdm12 WT (500 µL of 1 µM) was
mixed with an equimolar amount of 100% NBD-PE LUVs (500 µL of 1 µM NBD-PE) in a 1.5
mL microfuge tube at room temperature. At each recorded time point of the interaction the
sample tube was inverted 5 times to ensure even mixing, and a 60 µL aliquot of sample was
loaded into a quartz cuvette. The cuvette was washed between each time point sample.

12	
  

Measurements were acquired at 25˚C using a ZetaSizer Nano S (Malvern Instruments, UK) with
a 4-mW He-Ne laser (λ = 633 nm), and particle sizes were determined by back-scattering at
173˚. Data analysis was performed using DTS Nano software (Malvern Instruments, UK).

VI. Transmission Electron Microscopy (TEM)
LUVs of 100% NBD-PE (~0.9 mM) were plasma cleaned and imaged by negative
staining (uranyl acetate), both alone and after brief incubation (~5 min) with Mdm12 WT (10
µM). Images were collected at 18,500-150,000x on a Tecnai 12 G2 Spirit BioTWIN
transmission electron microscope (FEI, Oregon, USA) with an acceleration voltage of 80.0 kV.

VII. Fluoresence Titrations and Timecourse
Time course measurements. Fluorescence wavescans of NBD-PE (λex = 470 nm, λem =
500-600 nm) were performed using a Fluorolog 3-22 spectrofluorometer (HORIBA Jobin-Yvon)
equipped with a 450-W xenon lamp (λex = 470 nm), a photon-counting digital photomultiplier
(λem = 500-600 nm), and double grating excitation and emission monochromators (5 nm
bandpass; 5 nm bandpass). 250 µL reactions (20 nM Mdm12 WT; 0.4 µM NBD-PE) with DTT
(4 mM) or without, were briefly mixed at room temperature. Samples were then transferred to
quartz cuvettes (1 cm pathlength) and wavescans were measured as described above. Wavescans
were recorded consecutively at each time point for the duration of the time course, until the
fluorescence intensity reached a maximum (2-186 min). Samples were not mixed between
consecutive measurements. The fluorescence intensity (cps) at the NBD emission maximum (λex
= 530 nm) was plotted as a function of time, and fit using non-linear least-squares regression
(Kaleidagraph, Synergy Software, PA).
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VII. Stopped-flow Fluorescence
Pre-steady-state kinetics experiments were performed with an SX-20 stopped-flow
instrument (Applied Photophysics, UK). Samples were excited at 465 nm and emission was
detected using a 500 nm long-pass cutoff filter. Mdm12 and NBD-PE LUVs were loaded into a
1.0 mL syringes at double the final reaction concentration, respectively, and equal volumetric
mixing ratio of Mdm12: NBD-PE was used. The final concentration of NBD-PE was constant in
all experiments (1 µM) and the concentration of Mdm12 was titrated (0.025-2.5 µM). To test the
effect of reductant on the kinetics of lipid-binding, Mdm12 WT and Mdm12 ∆Ca+2 were
preincubated (~5 min) with 1 mM DTT before loading and initiating the lipid-binding reaction.
For calcium reintroduced experiments, Mdm12 ∆Ca+2 was preincubated in reaction buffer
containing 5 µM CaCl2 for ~5 min before samples were loaded and the lipid-binding reaction
was intiated. All experiments were performed in reaction buffer. Measurements were collected
for 10, 100, and 1000s reactions and data were analyzed using SX Pro-Data Viewer (Applied
Photophysics, UK). Triplicate fluorescent transients from a single experiment were averaged and
fit to multiexponential curves, in which an additional exponential term was added to account for
photobleaching. The rate of this fixed additional term was determined by NBD-PE—reaction
buffer equal-mixing control experiments.
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Results
I. Oligomeric State of Mdm12
A construct of full-length Mdm12 containing an N-terminal 6XHis-tag (His-Mdm12) was
expressed in E. coli and purified as described above. As also observed by Jeong, et al., 2016, the
TEV cleavage site was inaccessible to protease and only small amounts of TEV-cleaved Mdm12
could be formed by proteolysis (not shown). This suggests that the fold of the N-terminal region
of Mdm12 may occlude the TEV cleavage site. The elution profile of His-Mdm12 shows two
distinct species corresponding approximately to the MW of the Mdm12 monomer and dimer
(Fig. 6). Native PAGE analysis of Mdm12-containing fractions indicates that the distribution of
oligomers is dynamic, as either peak fraction redistributes into a dimer/monomer mixture
immediately upon elution. A large fraction of Mdm12 appears in earlier fractions suggesting
either that there is significant aggregation or that Mdm12 also forms higher-order oligomers.
A

A

B

Figure 6. Mdm12 exists as
multiple oligomeric states.
GFC run at 4˚C on an S75
column (A) and at room
temperature on an S200
column (B) separates Mdm12
into monomer/dimer fractions.
Mdm12-containing fractions
run on native PAGE indicate
this monomer-dimer equilibrium is dynamic as all peak fractions can redistribute into a
mixture of monomer (band 1)
and dimer (band 2).
B

C

AUC suggests that the dimeric species of Mdm12 is the most abundant oligomer (~85%,

S20,w ≈ 4S) both at low temperature (5˚C) and at room temperature (20˚C) (Fig. 7). However at
room temperature, Mdm12 exists in monomer/dimer equilibrium whereas a dimer/tetramer
mixture is observed at low temperature (Fig. 7A). Moreover, both the monomer and tetramer
Figure 7. Temperature affects the oligomeric state of Mdm12. (A) Continuous sedimentation coefficient distribution c(s) of Mdm12 at different15	
  
temperatures as measured by AUC. The molecular
weight corresponding to the main peak (s ~ 3.9 Svedbergs) is consistent with that of an Mdm12 dimer.
Analysis of c(s) distribution shows no concentration dependence on the distribution of different MW
species at low temperature (B) or at room temperature (A). Mdm12 exists as a mixture of two species,

this monomer-dimer equilibrium is dynamic as all peak fractions can redistribute into a
mixture of monomer (band 1)
and dimer (band 2).
A

B

C

Figure 7. Temperature affects the oligomeric state of Mdm12. (A) Continuous sedimentation coefficient distribution c(s) of Mdm12 at different temperatures as measured by AUC. The molecular
weight corresponding to the main peak (s ~ 3.9 Svedbergs) is consistent with that of an Mdm12 dimer.
Analysis of c(s) distribution shows no concentration dependence on the distribution of different MW
species at low temperature (B) or at room temperature (C). Mdm12 exists as a mixture of two species,
the monomer and dimer at room temperature, and the dimer and tetramer at low temperature.

comprise 15% of the total sample at high and low temperature, respectively, and remain in
constant proportion to the total amount of dimer (85%) (Table 2).
TABLE 2. ANALYTICAL ULTRACENTRIFUGATION PARAMETERS
Sample	
  

MW(1)
(kDa)

s(1)	
  
(Svedbergs)	
  

s(2)	
  
(Svedbergs)	
  

[m(2)]
![m(1)]	
  

RMS	
  error	
  
(A280)	
  

	
  

	
  

	
  

	
  

	
  

	
  

20˚C	
  

32.2	
  

2.44	
  

3.83	
  

2.76†	
  

0.013	
  

4˚C	
  

61.6	
  

4.06	
  

5.78	
  

0.073‡

0.0136	
  

	
  

	
  

	
  

	
  

	
  

	
  

† Corresponds to an average weight percentage of 15% for the monomer and 85% for the dimer.
‡ Corresponds to an average weight percentage of 87% for the dimer and 13% for the tetramer.

	
  
The association state of Mdm12 can be disrupted by the introduction of reductant DTT,
suggesting that Mdm12 forms disulfide-mediated oligomers (Fig. 8A). Mutagenesis experiments
suggest cysteine 92 (Mdm12 ∆C92S) in particular is critical in mediating the formation of the
Mdm12 dimer. Mdm12 ∆C92S exists as primarily a monomer even in the absence of DTT, and
moreover when pre-incubated with DTT Mdm12 ∆C92S exhibits no change in the distribution of
monomer and dimer equilibrium (Fig. 8B). In gel FITC scans showing NBD-PE bound to
Mdm12 illustrate that both dimer and monomer can capably bind lipids (Fig. 8A/B, NBD-PE).
Self-association of Mdm12 has been previously reported30,31, however previous results indicate
that His-tagged Mdm12 forms only the monomeric species. Moreover our finding that Mdm12

16	
  

dimerization is disulfide-mediated stands in contrast to structural evidence showing that Mdm12
forms

a

homodimer

mediated

by

swapping

of

the

highly

conserved

β1-strand.

In the reducing cellular environment it is possible that Mdm12 does not form disulfide-mediated
oligomers as it exists in the ERMES complex. On the other hand, there is no structural
information currently available for the large disordered loop containing residue C92 (residues
74-114), and given the finding that C92 is important for reversible dimerization it is possible that
it may play some role in Mdm12 assembly in vivo.
A

B

C

Figure 8. DTT and Ca+affect the oligomeric state of Mdm12. Mdm12 WT (A) and Mdm12 ∆C92S (B)
were incubated with NBD-PE LUVs at increasing DTT concentrations. At high DTT concentrations, the
higher MW species (dimer ~66 kDa) is shifted partially to the lower MW species (monomer ~33 kDa) as
imaged by coomassie staining. FITC gel images indicate both MW species have bound NBD-PE. Mdm12 ∆
C92S exists predominantly as the lower MW species even at low DTT concentration. (C) Ca2+ potentiates
Mdm12 WT sensitivity to DTT. FITC scans of preliminary gels indicate that the higher MW species of
Mdm12 ∆Ca2+ is less responsive to reduction by DTT than Mdm12 ∆Ca2+ with reintroduced calcium.

Interestingly, calcium may potentiate the effect of DTT on the oligomeric state of
Mdm12. FITC scans of preliminary native PAGE gels show that the change in fluorescence
intensity of the lipid-bound species of Mdm12 dialyzed in EGTA (Mdm12 ∆Ca+2) may be less
responsive to DTT than Mdm12 ∆Ca+2 pre-incubated with calcium ions (Fig. 8C). However,
FITC scans of both gels show minimal response to treatment with DTT. Also, FITC scans alone
are not sufficient to measure possible changes to the oligomeric state of Mdm12. Changes in
band intensity may only reflect changes in the ability of Mdm12 to bind lipids, and not
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changes in oligomeric state. In subsequent experiments the gels must also be stained to resolve
protein bands to ensure that the intensity of the bands measured by FITC also reflect relative
amounts of Mdm12.
II. Phospholipid Docking of Mdm12 in silico
Glide was used to dock a library of phospholipids into the binding site of Mdm12. The
library of candidate glycerophospholipid ligands was manually curated based on the
aforementioned MS findings of Mdm12-bound lipid species30,31 (Table 1). Fatty acid
composition was selected to mimic acyl chains found naturally in S. cerevisiae36. Mdm12 (PDB
5GYD) was prepared using the default Protein Preparation Workflow (Schrödinger) and a grid
was generated for the lipid-binding site of one monomer of the homo-dimer assembly, defined
by identifying the co-crystallized ligand. For the second round of docking specifically with PC,
another grid was defined with a NOE constraint to bias docking into generating a pose with the
tertiary amine of PC in proximity to the acidic residues hypothesized to play a role in forming
favorable interactions with choline headgroup. XP flexible ligand docking was then performed
using Glide with default settings. Nearly all generate poses were in the posture observed as in the
co-crystallized ligand, wherein the acyl chains lie within the SMP lumen and the headgroup is
solvent-exposed (Fig. 9A).
Interestingly, the hypothesized in vivo ligand (PC) generated the least favorable poses of
all species docked (Fig. 9B). Moreover, those generated showed an abnormal inverted pose in
which one acyl chain docked within the SMP lumen and the other occupied the expected
headgroup region, while the choline headgroup formed favorable contacts with the dimerization
interface. A second round of docking was performed in which the aforementioned NOE
constraints were defined to bias poses such that the choline headgroup was proximal to the
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A

B

D

E

PG(16:0/18:1(9Z))
XP GScore: -11.243

C

PC(14:1(9Z)/18:1(9Z))
XP GScore: -11.126

PI(14:0/18:1(9Z))
XP GScore: -12.859

F

PE(16:1(9z)/18:1(9Z))
XP GScore: -12.306

PS(16:1(9Z)/18:0)
XP GScore: -10.059

Figure 9. Top poses of Mdm12-docked phospholipd ligands. (A) The overall pose of cocrystallized lipid ligand (PE) with the acyl chains (olive) facing the SMP lumen, and the ethanolamine
headgroup (blue) exposed to solvent. The glycerol moeity is shown in gray. Residue-specific
interactions (H-bond:black, coulombic interaction:yellow) between the headgroup of the docked
phospholipid and the binding site of Mdm12 are shown for (B) phosphatidylcholine (PC), (C)
phosphatidylethanolamine (PE), (D) phosphatidylglycerol (PG), (E) phosphatidylinositol (PI), and
(F) phosphatidylserine (PS).

highly conserved, positively charged residues of interest. Only two poses could be generated in
the second round of docking, and only with one of three PC species, PC(14:1(9Z)/18:1(9Z)). One
of these poses had a highly favorable GlideScore (-11.126) while the other pose was relatively
unfavorable (-5.039). It is likely that the lipid-binding site of the Mdm12 is dynamic in vivo, and
this particular crystallized posture may not be representative of the PC-bound state. Likely a PCbound state would require a larger width of the lateral seam of the SMP domain proximal to the
dimerization interface. Of note, an Mdm12 monomer from this crystal structure alone can easily
accommodate a choline headgroup. This is, if repeated with only the monomer PC would likely
generate a large number of favorable poses.
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PI (14:0/18:1(9Z)) generated the two best poses of all docked ligands (Fig. 9E). Although
the inositol headgroup is large and non-ionized, it forms extensive polar contacts with the main
chain atoms of conserved residues W261, I262, and N263. Of note, the previous MS data
indicates that Mdm12 is highly enriched in bound PI species relative to normal cellular
concentrations in S. cerevisiae. Docking of PG and PS species also generated a large number of
poses with favorable XP GlideScores (Fig. 9D & F). Similarly, the conserved residues of interest
participating in favorable contacts with inositol headgroups also participated in extensive
favorable contacts with both PG and PS headgroups. However, no ligands other than PE, and PC
in the second round of docking, formed favorable contacts with E255, the highly conserved
residue previously hypothesized to specifically play a critical role in headgroup selectivity. In
fact, PI, PG, and PS all formed significant unfavorable interactions with E255. Perhaps E255
may play a role in headgroup specificity by a mechanism of negative headgroup selectivity
(forming unfavorable interactions with particular headgroups) rather than by positive selectivity
as previously hypothesized.
Docking of the cognate ligand PE generated the most favorable docking scores on
average. Notably, the protein sample used to determine the Mdm12 crystal structure was purified
from E. coli, in which PE composes ~80% of the total lipid composition. The co-crystallized
lipid of the structure used for docking was modeled to be a completely saturated species of PE, a
species not commonly found in vivo. Moreover, MS analyses of lipids bound to Mdm12 purified
from E. coli have shown that ~80% of bound lipid is indeed PE. Therefore, the binding site used
for Glide docking represents a conformation biased for favorable PE docking.
Headgroup specificity, however, is not the primary determinant of favorable docking.
Rather, interactions between the SMP lumen and the acyl chain compose the vast majority of

20	
  

favorable binding interactions (Fig. 10). In all cases lipophillic contacts between the acyl chains
and hydrophobic residues in the SMP lumen are significantly more abundant than electrostatic
interactions between lipid head-groups and the conserved proximal residues (Fig. 10B & C).
However, poses that had fewer favorable headgroup contacts also had fewer favorable lipophilic
interactions and inversely, those with many favorable headgroup contacts also had a large
number of favorable lipophilic interactions. Hence, for any given lipid it cannot be said whether
the headgroup specifically was the cause for the generation of the favorable pose. Additional
docking studies in which the acyl chain is kept constant and in a fixed conformation can be
performed to more specifically investigate only the effects of particular lipid headgroups on
docking score.
Taken together, multiple lipid ligands generate highly favorable poses within the
crystallized binding site and it is likely that Mdm12 binds multiple lipid species as it exists in the
ERMES complex in vivo. Moreover, this study suggests that headgroup specificity plays a
minimal energetic role in Mdm12 lipid binding.

A

B

C

Figure 10. XP Glide docking of glycerophospholipids. (A) Box plot of XP GlideScore by phospholipid
shows that multiple lipids dock with highly favorable docking scores except for PC. PE docks with the
most favorable score on average and PI docking generated the most favorable pose overall. The XP GlideScore depends on both electrostatic (B) and lipophillic vdW (C) interactions between Mdm12 and the
docked ligand.
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III. Mdm12 Remodels Synthetic Bilayers
The effect of Mdm12 binding on overall liposome size and morphology was assessed by
time course DLS experiments and transmission electron microscopy. Mdm12 induced large-scale
morphological changes including fusion, tubulation, tethering, and solubilization of 100% NBDPE liposomes (Fig. 11). Prior to interaction with Mdm12, NBD-PE LUVs were monodisperse
with an approximate hydrodynamic radius (DH) of 100nm as measured by DLS, and exhibited
normal morphology (Fig. 11A/E). DLS also showed that purified Mdm12 alone is solution was
also monodisperse (DH ~1-10 nm) prior to interaction with NBD-PE LUVs.
Upon Mdm12-binding TEM images illustrate dramatic changes in the overall
morphology of the LUVs. Moreover, time course DLS experiments suggested that Mdm12 lipidA

B

C

D

E

F

G

H

Figure 11. Mdm12 induces vesicle fusion and bilayer reorganization. (A/E) Stable large unilamellar
vesicles (LUVs) composed of 100% NBD-PE can be formed in isolation (DH ~100 nm). (B) Upon intial (5
min) interaction with Mdm12 NBD-PE LUVs form aggregates. (C) Between 14-63 min interaction the
predominant species measured by DLS and visualized by volume PSD is approximately the size of the
Mdm12 in isolation (DH ~1-10 nm). (D) Aggregates again begin to form at 71 min and continue to form until
reaction equilibrium at 90 min. LUVs and Mdm12 were incubated at equimolar concentrations. (F-H) Representative TEM images of the different liposome morphologies induced upon Mdm12 interaction with
LUVs are shown.
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binding is a complex multi-step reaction, and may be broadly separated into three distinct phases.
The first phase occurs upon initial interaction (5 min) at which point liposomes begin to form
large aggregates (Fig. 11C/F). A second phase is characterized by a sudden decrease of the
average particle size (DH ~1-10nm) in the sample as measured by volume distribution.
Interestingly, this is the same size as Mdm12 alone in solution. This second phase is prolonged,
and the average particle size in solution remains constant for ~60 min at room temperature (Fig.
11E/G). A third and final apparent phase shows a second phase of aggregation, in which the
average particle size increases to form three distinct populations (DH ~50nm, ~100-200nm, and
>10µm) (Fig. 11G). It cannot be said with certainty whether this size distribution of aggregate is
distinct from that formed in the initial aggregation phase.
IV. Kinetics of Mdm12 Lipid Binding
A fluorescence-based approach was used to investigate Mdm12 lipid-binding at finer
kinetic resolution. Stopped-flow was used to perform rapid mixing experiments in which Mdm12
and LUVs of 100% NBD-PE were mixed at equal volumes, where the relief of NBD selfquenching was interpreted as a readout for Mdm12—lipid interaction. Stopped-flow results
corroborated the findings from DLS experiments, also indicating that Mdm12 interacts with
liposomes via a complex multiphasic reaction consisting of at least three different kinetic phases
(Fig. 12). First, there is an initial rapid phase (~10 ms) and that accounts for only a small
increase (<5%) in the overall fluorescence signal (Fig. 12A). This is followed by a longer (~1-40
sec) secondary phase, which contributes a much larger proportion of the total fluorescence
signal(~50%) (Fig. 12B). The reaction never saturated even at the maximum programmable time
interval on the stopped-flow apparatus (1000 sec). Rather, the reaction enters a third phase (~50
sec) that appears linear at the timescales measured by stopped-flow, and also contributes
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A

B

C

D
[Mdm12]:[Lipid]
1:20
1:10
1:5
1:2.5

Figure 12. Kinetics of Mdm12 Lipid Binding. Three distinct phases of
Mdm12 interacting with liposomes are apparent. (A) The first phase is
rapid (~10 ms) and contributes minimally to the overall fluorescence
increase (<5%). (B) The second phase occurs subsequently (1-40 s) and
is followed by (C) a third linear phase, which is the longest in duration.
(D) The rates and amplitude of all three phases are dependent on the
concentration of Mdm12.

significantly (~50%) to the overall Mdm12-induced fluorescence change (Fig. 12C).
Importantly, the rate and magnitude of the fluorescence response is dependent on the
concentration of Mdm12 added, suggesting that the combined overall reaction is governed by at
minimum first order kinetics with respect to the Mdm12 concentration (Fig. 12D). However, the
fluorescence output from NBD dequenching is a combination of multiple potential reactions (e.g.
lipid phase change, Mdm12 lipid-binding). This ambiguity greatly confounds data analysis and
makes it difficult to distinguish and characterize each kinetic phase individually.
Stopped-flow measurements also showed that both DTT and calcium affect the kinetics
of Mdm12 lipid binding. Pre-incubation of Mdm12 with 1 mM DTT increases the rate and
overall magnitude of Mdm12 lipid binding (Fig. 13A). Although our finding that Mdm12
dimerization is disulfide-mediated stands in contrast to the β1-strand swap observed in the
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Figure 13. Calcium and DTT affect the kinetics of Mdm12 lipid binding. (A) Mdm12 WT and liposomes
of 100% NBD-PE were rapid-mixed at equimolar concentration. In the presence of reductant DTT, the rate
of reaction and the amplitude of the overall fluorescence signal was amplified. DTT alone had no effect on
the dequenching of NBD fluorescence. (B) When calcium is removed by dialysis with EGTA-containing
buffer (∆Ca+2), the overall fluorescence signal and the rate of reaction also increase. When calcium is reintroduced the kinetics of interaction are restored to that of Mdm12 WT before dialysis. Calcium alone has no
effect on dequenching of NBD fluoresence. (C) The absence of calcium and presence of reductant have a
combinatorial effect on the kinetics of interaction.

crystal structure, biochemical studies accompanying the structure similarly observed that Mdm12
binds lipids with greater affinity as a monomer rather than a dimer.
Similarly, the removal of calcium (Mdm12 ∆Ca+2) also increases the overall reaction rate
and fluorescence response (Fig. 13B). Upon the reintroduction of calcium (5 µM) to Mdm12
∆Ca+2, the reaction rate and fluorescence signal are restored to wild type levels. Interestingly,
Mdm12 ∆Ca+2 also treated with DTT exhibits a combinatorial effect on reaction kinetics. That is,
the presence of reductant in addition to the absence of calcium increases the overall rate and
amplitude of the fluorescence response greater than either treatment alone (Fig. 13C). Control
experiments mixing DTT or calcium with NBD-PE LUVs alone confirm that the fluorescence
response is attributable to modulated Mdm12 activity. Calcium is a tightly regulated and potent
secondary messenger at MAMs, and this is the first direct biochemical evidence that suggests it
may affect MAM function via ERMES.
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Because Mdm12 lipid-binding does not reach equilibrium at time intervals accessible by
stopped-flow, another NBD dequenching-based method was used to observe the reaction until
saturation. A spectrofluorometer was used to collect consecutive wavescans (500-600 nm) of
Mdm12 lipid-binding reactions until signal saturation (Fig. 14). Binding of Mdm12 WT with
NBD-PE LUVs saturated ~60 min (Fig. 14B), corresponding to the same time at which the
beginning of the second aggregation phase was observed in DLS time course experiments. Time
course measurements of Mdm12 treated with 1 mM DTT corroborated stopped-flow results, and
relieved NBD self-quenching at a faster rate and induced a larger response than Mdm12 alone
(Fig. 14A/C). Moreover, DTT-treated Mdm12 lipid-binding reactions took longer to saturate
(~120 min vs. ~60 min). Additionally, the emission maximum of NBD in the DTT-treated
reaction is further blue-shifted (λem= 527 nm vs. λem= 535 nm) (Fig. 14D) indicating NBD on
average is in a lower dialectric environment. Although not conclusive this could suggest that
more total lipid is bound at equilibrium to DTT-treated Mdm12, which would support the
previous findings that the Mdm12 monomer binds lipids more readily than the dimer.
A

B

C

D

Figure 14. Mdm12 Lipid-Binding Reaction
Time Course. Lipid binding reactions were
performed (20 nM Mdm12; 0.4 µM
NBD-PE) for both Mdm12 WT (B) and
Mdm12 WT preincubated with DTT before
lipid-binding (A) and consecutive wavescans
were recorded until saturation. Mdm12 preincubated with DTT relieved self-quenching of
NBD significantly faster and induced a much
larger response (2.4x) than untreated Mdm12
(C). The reaction also proceeded for 186 min
until reaching full saturation (not shown),
whereas lipid-binding saturated after ~60 min
with untreated Mdm12. In both experiments
NBD-PE LUVs alone measured a λem= 557
nm, and a blue shift was observed upon addition of Mdm12. However, the emission
maxima differed between DTT (λem=
527 nm) and untreated Mdm12 (λem= 535
nm) lipid-binding (D).
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Discussion
Because ER-mitochondria contact sites are major conduits of lipid trafficking
independent of the endomembrane system, illumination of the molecular basis of ERMESmediated phospholipid transport is poised to uncover novel concepts in membrane biology.
Membrane contact sites are ubiquitous yet also enigmatic. Understanding how the SMP domaincontaining subunits of ERMES assemble to recognize, extract, and transport phospholipids could
possibly characterize a general mechanism for lipid transport at membrane contact sites in
general. To this end, this study sought to investigate the assembly state and lipid binding
properties of ERMES subunit Mdm12 in isolation.
Our finding that Mdm12 exists primarily as a dimer in dynamic equilibrium corroborates
previous findings30,31,41. However, in this study we found Mdm12 oligomerization to be
primarily disulfide-mediated and facilitated largely by C92 disulfide bond formation. Of note,
our biochemical analyses of Mdm12 association state were performed using a full-length Nterminal His-tagged construct, before structural information was available. Crystal structures
show that Mdm12 forms dimers mediated by contacts between conserved β1-strands.
Interestingly, a recent structure of Mdm12 demonstrates that β1-mediated dimerization is
promiscuous, in that β1-strands can mediate self-association by either strand swapping30 or
asymmetrically with only one strand engaged at the dimer interface (Fig. 15A/C)41. Additionally,
all structures to date show a ‘non-crystallographic’ dimer mediated by large crystal contact
surfaces that exceed the buried surface area of the bona fide dimer interface (Fig. 15B). The
unresolved disordered loop containing C92 is proximal to this interface, and because our
construct contains an N-terminal His-tag that likely occludes β1-strand interaction, the dimer
observed

in

this

work

is

likely

distinct
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from

that

previously

investigated.

A

B

Figure 15. Dimerization interface of
Mdm12. (A) β1-strand-swapped dimer
previously shown from Jeong et al.
(2016). (B) Non-swapped/non-crystallographic dimer corresponding to an
‘anti-parallel’ arrangement along helix
H2 proximal to C92. This large contact
interface may directly involve C92 and is
observed in every Mdm12 structure to
date. (C) An asymmetric pseudo
‘head-to-head’ dimer involving only the
β1-strand from monomer A.

C

Figure adapted from AhYoung et al. (2017)

Moreover, all purification and biochemical studies of Mdm12 to date have been
performed under highly reducing conditions (2.8 mM31, 41, and 5 mM30 BME) and AhYoung et
al. (2015) even performed mutagenesis of C92 to improve sample homogeneity for
crystallization41. Although this disordered region is variable, little is known about the local redox
environment at membrane contact sites and it is possible that disulfide-mediated dimerization has
physiological function.
Although it is widely assumed that ERMES mediates non-vesicular lipid transport, this
study is the first to investigate Mdm12—bilayer interaction and demonstrate the effect of an
ERMES subunit on overall bilayer morphology. It is clear from the experimental findings
presented above that Mdm12 significantly disrupts the integrity of lipid bilayers composed of
NBD-PE. It is important to note that when derivatized with an NBD moiety conjugated to the
headgroup PE no longer exhibits polymorphic phase behavior42-44. Rather NBD-PE is
characterized as a lamellar lipid, hence its ability to form stable bilayers averse to high curvature.
Although a molecular interpretation of the mechanism of Mdm12—bilayer interaction is still
lacking, the data presented in this study clearly demonstrate the ability of Mdm12 to disrupt lipid
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bilayers and induce significant polymorphism. Real-time stopped-flow and DLS measurements
also show that reaction progression follows a defined progression of Mdm12-mediated bilayer
changes. Taken together we propose a coarse working model for the mechanism of Mdm12
action on lipid bilayers (Fig. 16).

Figure 16. Proposed Model for Mdm12—Bilayer Interaction. In isolation Mdm12 significantly disrupts
synthetic bilayers (NBD-PE). These changes occur in distinct phases at different rates. Representative TEM
images showing putative Mdm12-induced morphologies corresponding to the propposed model. (1)
Mdm12 must first interact with the exterior surface of liposomes, however, the specific interactions that
mediate association are unknown. (2) A small amount of tethering is apparent and aggregation accompanies
the destabilization of the bilayer. (3) This induces bilayer fusion, and (4) subsequent lysis or solubilization.
The reaction continues to equilibrium until again aggregate is formed, which may or may not distict from
aggregates formed in previous phases.
Schematic adapted from R.I. Abu-Ghazaleh et al. 1992
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Mdm12 first binds the exterior leaflet of bilayers likely by a combination of electrostatic and
hydrophobic interactions, however the energetic basis of this interaction is unknown. Binding
induces liposome clustering and features of membrane tethering, and tubulation is also observed.
Bilayer destabilization induces aggregation and fusion of clustered liposomes. As shown using
DLS average particle size decreases to the size of Mdm12 alone in solution, possibly indicating
membrane solubilization. Although there is no direct evidence of the ability of Mdm12 to breach
the lipid bilayer, from TEM images we speculate that the integrity of liposome
compartmentalization is compromised. Large granular aggregates are visible in TEM images and
could be representative of solubilized lipid—Mdm12 aggregates. Of additional note, stoppedflow measurements showed that calcium modulates the lipid-binding of Mdm12. Because ERmitochondria contact sites are major conduits for calcium exchange, a deeper understanding of
this effect is of particular interest.
These findings stand in apparent contrast to the notion that ERMES facilitates monomeric
lipid transport independent of fusion and large-scale membrane morphological changes.
Preliminary results have indicated that other SMP domain-containing proteins facilitate lipid
transport without concurrent fusion4. Mdm12 also bridges the connection between juxtaposed
membranes via interaction with Mmm1 and Mdm34. Thus, Mdm12 is assumed to be a
transducer of lipid transport and have limited direct contact with the bilayer. It is very likely that
Mdm12 interacts differently in physiological context. Regardless, these results provide a starting
point to address the major question of how SMP domain-containing proteins are able to extract
and deposit lipids into adjacent bilayers at membrane contact sites.
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Appendix A
Analysis of SS-31 Lipid Binding Kinetics
I. Abstract
The SS-31 peptide is a synthetic tetrapeptide containing an alternating cationic-aromatic
motif that represents a first-in-class therapeutic which restores compromised mitochondrial
bioenergetics (Fig. A1A). By modulating the ultrastructure of the mitochondrial inner membrane
(IMM) SS-31 is thought to restore oxidative phosphorylation, leading to clinical improvements
in a diverse set of complex diseases. However, the biophysical mode of SS-31 action remains
uncharacterized. Despite bearing a +3 net charge at physiological pH, SS-31 is readily taken up
by all tested cell types to date and targeted specifically to the IMM46. Intriguingly, there is no
apparent receptor or transporter-mediated requirement for uptake or localization, and the
distribution of SS-31 within mitochondria was found to be membrane potential independent47.

A

B

C
Figure A1. SS-31 specifically binds TOCL.
A) The chemical structures of SS-31 and
fluorescent labeled [ald]SS-31.
B) Proposed model illustrating binding
mode of SS-31 to TOCL.
C) Chemical structures of CL variants
TOCL, dCL, and the CL remodeling
intermediate MLCL, which accumulates in
the mitochondria of BTHS patients.
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Using a combination of nuclear magnetic resonance (NMR), Rayleigh scattering, and
fluorescence-based approaches, it was later revealed that SS-31 selectively binds to cardiolipin
(CL), a unique phospholipid which has two phosphate headgroups connected by a single glycerol
moiety, and is found principally in the IMM48. From these data it was proposed that SS-31 and
tetraoleoyl cardiolipin (TOCL) interact at a 1:1 molar ratio, in which electrostatic interactions
between the two cationic residues of one SS-31 molecule and the two phosphate head-groups of
TOCL align the aromatic residues for hydrophobic interaction with the acyl chain region (Fig.
A1B). This study explores the potential use of SS-31 as a therapeutic for Barth Syndrome
(BTHS), a multisystemic disorder caused by mutation of the gene encoding tafazzin, the
transacylase responsible for the remodeling of acyl chains during TOCL biosynthesis. BTHS
patients show decreased levels of CL and an accumulation of the biosynthetic intermediate
monolysocardiolipin (MLCL) (Fig. A1C). The following kinetic analysis of the interactions
between SS-31 and CL variant-containing bilayers points to the potential use of SS-31 to treat
BTHS, and gives key mechanistic insights into the mode of SS-31 binding.

II. Materials and Methods
Steady-state fluorescence. Stock solution of [ald]SS-31 (250 µM) was prepared by resuspension of lyophilized peptide in reaction buffer (20 mM HEPES [pH 7.5], 100 mM NaCl).
CL-containing LUV stock solutions (250 µM) were prepared as described above. Samples were
mixed at each respective concentration LUVs and incubated for 20 min then transferred to 250
µL quartz sample cuvettes (4x4-mm). Measurements were made using a Spex Fluorolog 3-22
spectrofluorometer

(HORIBA

Jobin-Yvon)

with

double-grating

excitation/emission

monochrometers (Ex: λ = 360 nm, Em: λ = 400-600 nm, 2-nm bandpass). ∆Emission at 461 nm

II	
  

was used to define specific binding, and the data were fit to the Hill-equation (Eqn. 1) to
extrapolate binding parameters.
𝜃=

𝑛

[L]
𝑛
𝐾𝑑 +[L]

(Equation 1)

Stopped-flow fluorescence. Pre-steady-state kinetics experiments were performed with
an SX-20 instrument (Applied Photophysics, UK). Samples were excited at 360 nm and emission
was detected using a 400 nm long-pass cutoff filter. Peptide and LUVs were loaded into a 1.0
mL syringes at double the final reaction concentration, respectively, and equal volumetric mixing
ratio of [ald]SS-31: LUVs was used. The final concentration of [ald]SS-31 was constant in all
experiments (1 µM) and the concentration of CL-variant LUVs was titrated. All experiments
were performed in reaction buffer (20 mM HEPES [pH 7.5], 100 mM NaCl). Data were analyzed
using SX Pro-Data Viewer (Applied Photophysics, UK). Triplicate fluorescent transients from a
single experiment were averaged and fit to multiexponential curves, in which an additional
exponential term was added to account for photobleaching. The rate of this fixed additional term
was determined by peptide : reaction buffer equal-mixing control experiments.

III. Results
Biphasic membrane binding by [ald]SS-31
The association between [ald]SS-31 and CL-containing bilayers was found to be a
biphasic process characterized by two distinct kinetic phases, an initial rapid phase followed by a
subsequent slow phase (Fig. A2). The rate of the fast phase (k1) linearly increased with
accessible lipid concentration upon titration with liposomes containing TOCL, dCL, or MLCL.
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D

C
dCL

E

MLCL

F

Figure A2. Kinetics of SS-31 binding to CL-containing bilayers. (A-C) Representative stopped-flow
fluorescence transients of [ald]SS-31 (1 µM) added to liposomes containing 50 mol% of CL variants at the
indicated lipid concentration. Binding of [ald]SS-31 to liposomes is biphasic. (D-F) Association (kon) and
dissociation (koff) rate constants determined by pseudo first-order approximation for the first phase of
[ald]SS-31 binding to CL variants. Insets show the first 30 ms binding transients identifying the first phase.

Moreover, the rate of the fast phase contributed significantly more to the overal fluorescence
increase (~60-95%). The forward rate of the rapid association phase (k +1) was approximately
3.60 µM-1sec-1 for each CL-variant, whereas the reverse rate of the phase (k -1) differed between
species. The differences in the affinity constants (KD) that were extrapolated from pre steadystate kinetic measurements are hence, most largely attributable to variations in the reverse rate
constant k -1. The slow rate, however, was not dependent on the lipid concentration and remained
approximately constant at ~0.4 s-1 (not shown) for all CL species, indicating this is either a zeroorder process or a first-order process subsequent to the first concentration-dependent reaction.
Steady-state measurements also showed close agreement with pre-steady state results, and
indicate that [ald]SS-31 binds with low micro-molar affinity to bilayers containing TOCL, dCL,
and MLCL (Fig. A3).
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IV. Discussion

A

B

C

D

Taken together, these results can be
represented by a minimal model for the
kinetic mechanism of [ald]SS-31 bilayer
association:	
  

where the kinetic parameters shown are
those

measured

for

TOCL-containing

bilayers, and the peptide and liposomes are
represented by 𝑃 and 𝐿 , respectively. P:L

Figure A3. Equilibrium binding of SS-31 to CL-containing bilayers.
(A) Emission spectra of [ald]SS-31 (1 µM) incubated to equilibrium (20
min) with liposomes containing 50 mol% TOCL of 100 mol% POPC (B).
(C) Saturation binding curves of [ald]SS-31 with increasing concentrations
of liposomes containing 50 mol% of the respective CL variants shown.
Curves were fit to Hill expansions of Langmuir binding isotherms, and
fitted parameters were reported with the standard deviation and as the mean
of triplicate experiments (D).

represents the product of the initial rapid
reaction, and P:L* represents the product of the subsequent slow reaction phase. The fast phase
likely correspond to an initial phase bilayer interaction mediated by electrostatic and
hydrophobic interactions between the basic and aromatic residues of SS-31. In contrast the
slower phase may correspond to the alignment of peptides within the bilayer via peptide—
peptide interactions, or represent alterations in bilayer properties such as interfacial packing.
Of particular note SS-31 binds MLCL-containing bilayers with similar affinity to TOCLcontaining bilayers, supporting the notion that SS-31 may well be effective in targeting the IMM
of mitochondria in Barth Syndrome patients, and possibly in ameliorating the characteristic
bioenergetics deficiencies. Moreover, the kinetics of [ald]SS-31 binding to CL-containing
bilayers are generally the same for TOCL, dCL, and MLCL, in which there is rapid phase
dependent on lipid concentration followed by a subsequent slow phase that does not depend on
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lipid concentration. Although k -1 differed between CL-variants, the other measured parameters
k -1 and k 2 were consistently similar. Interestingly the Hill coefficients for TOCL and MLCL
binding were greater than that measured for dCL, and this may represent subtle differences in
head-group dependent SS-31—CL interactions. Changes in head-group geometry and chemistry
may also affect interfacial packing and the alignment of peptides already bound to the bilayers.
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